Business
ViewRay® Announces First International MRIdian® Installation at Seoul National University Hospital
ViewRay® Announces First International MRIdian® Installation at Seoul National University Hospital.
About this update from Viewray, Inc.
[{"type":"text","content":"\n\n\n\nViewRay® Announces First International MRIdian® Installation at Seoul National University Hospital\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nViewRay® Announces First International MRIdian® Installation at Seoul National University Hospital\nClinical Team Prepares for Adaptive Therapy and Other Advanced MRI-Guided Treatments\nPR Newswire\nCLEVELAND, Sept. 15, 2015\n\n\n\nCLEVELAND, Sept. 15, 2015 /PRNewswire/ -- ViewRay, Inc. (OTCQB:VRAY) announced today the first international installation of its MRIdian System, the world's first and only MRI-guided radiation therapy system that images and treats patients simultaneously, at Seoul National University Hospital, a leading healthcare facility in Korea.\n\n\"We pride ourselves on offering the most advanced, state-of-the-art treatment options to our patients; therefore, MRI-guided radiation therapy was a must-have,\" said Hong-Gyun Wu, M.D., Ph.D., Professor and Department Chairman of Seoul National University Hospital. \"We are proud to be the first MRI-guided therapy center in Asia and one of the first in the world to use this breakthrough technology. The MRIdian system allows us to see the tumor and surrounding soft tissues both before and during treatment, so we can adapt to changes in the patient's anatomy.\"  \n\nThe SNUH team expects to begin treating patients in the next few weeks and intends to develop various treatment protocols and publish their research. Along with treatments of the lung, liver and breast, an area of particular interest to the hospital is the use of MRIdian for spine radiosurgery due to its ability to view the spine, spinal cord and adjacent tissue during treatment. \n\n\"The installation at SNUH is our first overseas installation and the beginning of our international expansion as MR-guided radiation therapy is embraced as an indispensable tool in the treatment of cancer,\" said Chris A. Raanes, President and Chief Executive Officer of ViewRay. \"We are pleased to be working with such a world-class research institution. This marks the start of bring...